Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 trial of nivolumab plus multisite radiotherapy for advanced gastric cancer
jRCT1011200013Phase 1Completed
- Sponsor
- Hokkaido Gastrointestinal Cancer Study Group:HGCSG
- Start
- Dec 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nivolumab in gastric cancer (GC), sponsored by Hokkaido Gastrointestinal Cancer Study Group:HGCSG. Primary endpoint: safety. Started Dec 2020; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT1011200013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011200013.